My Patent License Says What?

May, 16th, 2019

By: Benjamin N. Luehrs Generic forum selection clauses in patent license agreements can prevent licensees from trying to invalidate licensed patents at the United States Patent and Trademark Office (USPTO). A recent Federal Circuit Opinion, [Read More…]

Tech and Telecom Giants Take the Lead in the Self-Driving Vehicle Patent Race

May, 13th, 2019

By Patrick D. Duplessis These days it seems almost every article or news report about self-driving vehicles (SDVs) includes the prophecy that the automobile will soon resemble a “smartphone on wheels.”  That oft-repeated phrase alludes [Read More…]

Stop Infringers At The Border

April, 18th, 2019

By Christopher J. Stankus Section 337 Investigations at the International Trade Commission (“ITC”) can be a vital weapon for patent owners to protect their U.S. intellectual property against infringing imports. Section 337 Investigations are resolved [Read More…]

Claiming Software Patents in 2019

April, 4th, 2019

By Andrew P Siuta Rapid innovation makes it difficult to create a computer technology system that is not obsolete 20 years from its conception. However, with proper drafting techniques a patent attorney can write a [Read More…]

TC Heartland: The End of Patent Venue as We Know It (But Patent Owners are Doing Fine)

April, 2nd, 2019

By Benjamin N. Luehrs Odds are, if you work at all in the patent space, you’ve heard a bit about the Supreme Court’s 2017 decision in TC Heartland LLC v. Kraft Foods Group Brands LLC, [Read More…]

WHIPgroup defends United Race Parts in Patent Infringement Claim

March, 21st, 2019

Kluhsman Machine, Inc. has sued NASCAR Supplier United Race Parts, LLC in Statesville, North Carolina alleging infringement of its patent to “flower” lug nut sockets used in motorsport wheel guns.

WHIPgroup Files ITC Complaint On Behalf of RegenLab

March, 8th, 2019

WHIPgroup has filed a Complaint before the United States International Trade Commission (ITC) on behalf of its client RegenLab USA. The Complaint alleges that RegenLab’s US Pat. No. 10.064,894, directed to a blood separator system [Read More…]

“Highly” Patentable Subject Matter: Legalization Creating a New Patent Thicket

February, 19th, 2019

By Mackenzie L. Long For the past few decades software and pharmaceutical patents have been two industries dealing with and building patent thickets. Many inventors and companies in these industries wish that they could have [Read More…]

Federal Circuit Restates Fees are not “a Penalty for Failure to Win a Patent Infringement Suit.”

February, 12th, 2019

By William L. Birks “The court in exceptional cases may award reasonable attorney fees to the prevailing party.” 35 U.S.C. § 285 While every prevailing party would seek attorney fees if they could, it’s important [Read More…]

© Copyright 2019 Whitmyer IP Group